Article info
Leading article
IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn’s and Colitis
- Correspondence to Dr Miles Parkes, Gastroenterology Unit, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK; miles.parkes{at}addenbrookes.nhs.uk
Citation
IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn’s and Colitis
Publication history
- Received May 4, 2019
- Revised June 3, 2019
- Accepted June 4, 2019
- First published July 3, 2019.
Online issue publication
November 14, 2019
Article Versions
- Previous version (7 August 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.